SomaGenics miR-ID Platform and Assays | GenomeWeb

SomaGenics miR-ID Platform and Assays

Oct 07, 2015

SomaGenics has launched its miR-ID platform and assays for detecting miRNA using circularization-based RT-qPCR. The assays are highly sensitive, use single-dye detection, and can discriminate between miRNA isoforms with single nucleotide differences at any position along the molecule, said SomaGenics in a statement. The technology works well with all sample sources, including RNA, cell lysates, and tissue lysates. It also requires no enrichment for the analysis of total RNA for small RNAs, although it does analyze enriched fractions as well.

More Like This

Feb 17, 2017

Swift Biosciences Accel-NGS XL Library Prep Kit

Swift Biosciences has launched the Accel-NGS XL Library Prep Kit for whole-genome sequencing on Pacific Biosciences instruments. The kit has a four-hour workflow and has been optimized for PacBio's single molecule real-time sequencing technology.

Feb 16, 2017

Cofactor Genomics Pinnacle Assay

Cofactor Genomics has launched Pinnacle, an RNA-based oncology assay which provides insight into a patient's cancer profile. The assay reports on both aberrant oncology-relevant gene expression and known cancer gene fusions detected in the tumor sample. It uses the company's software to compare each patient's cancer expression profile to Cofactor's database of thousands of expression profiles from the same cancer type, the company said. Pinnacle is currently approved for use with formalin-fixed, paraffin-embedded tumor tissue.

Feb 16, 2017

MagBio Genomics Blood STASIS 21-CcfDNA Tube

MagBio Genomics has launched the Blood STASIS 21-ccfDNA tube for venous whole blood collection and room temperature stabilization of circulating cell-free DNA. The tube is a direct draw whole blood collection system that contains a proprietary reagent that prevents post-collection release of genomic DNA from white blood cells. It allows room temperature transport and storage of blood for 21 days, and epithelial cell for 8 days, the company said.

Feb 16, 2017

Immucor MIA FORA NGS HLA Typing Assay

Immucor has launched the MIA FORA NGS FLX HLA Typing assay that provides comprehensive coverage of up to 11 HLA genes. The assay provides whole gene coverage all major HLA gene regions, including whole gene coverage for HLA-A, B, C, DPA1, DQA1, and DQB1; all exons and introns for HLA-DRB1, 3, 4, 5 except partial coverage for exon 6 and intron 1; and all exons and introns between exons  and 4 for HLA-DPB1. Clinicians can prep and sequence the sample in less than 24 hours, and have the option to choose between a 5, 6, 9, or 11 gene kit for testing.

Feb 16, 2017

SoftGenetics GeneMarker HTS Software

SoftGenetics has launched GeneMarker HTS software for analysis of the mitochondrial genome in both forensic and clinical research applications. The software provides a streamlined workflow for forensic and medical research mitochondrial NDa data analysis from next-generation sequencing systems such as the Illumina and Ion Torrent platforms. It aligns data to a reference, and optimizes detection of INDELS and discovering variants, including SNPs, INDELS, and heteroplasmy. The software also includes quick export to EMPOP, user management, audit trail capabilities, synchronized comparison of multiple samples, customizable viewing, and reporting to protect health information.

Feb 16, 2017

Genomenon Mastermind

Genomenon has launched Mastermind, an analytic and data visualization tool that accelerates gene and variant curation. The software mines millions of medical publications and delivers a comprehensive knowledge base of disease-gene-variant relationships curated from primary medical literature, organized into clinical categories, and prioritized by the strength of evidence, the company said. Mastermind has reviewed literature and found associated variants for all the genes from Thermo Fisher Scientific's Ion AmpliSeq comprehensive cancer panel; Illumina's TruSight Tumor 170 solid tumor cancer panel; Thermo Fisher's and Fulgent's hereditary cancer panels; and Thermo Fisher's, Illumina's, and Fulgent's cardiomyopathy panels.

Feb 14, 2017

PreventionGenetics PGxome

PreventionGenetics launched the newly expanded PGxome whole-exome sequencing tests. In addition to diagnostic whole-exome testing, the PGxome Health Screen is now available to healthy individuals who want to learn more about their carrier status for recessive disorders and susceptibility to adult onset illnesses. Pharmacogenomic testing will be added to the PGxome test menu soon, PreventionGenetics said. 

Feb 10, 2017

Cole-Parmer DNA Prep Kit by Arcis Biotechnology

Cole-Parmer has launched the DNA Prep Kit by Arcis Biotechnology. The Arcis kit can be used for DNA and/or RNA extractions from fluids, such as blood, and requires as little as 30 µl of sample. It uses a two-step workflow that prepares samples in three minutes with high yields. The product is ideal for PCR, real-time PCR, isothermal amplification, sequencing, genetic profiling, and forensic studies, and can be easily integrated into automated processes, the company said. 

Feb 09, 2017

Courtagen Spotlight Gene Panels for Neurology and Endocrinology

Courtagen Life Sciences has launched 17 new gene panels in its Spotlight line of tests, expanding its menu in neurology, endocrinology, and other disease areas. The new tests include several pain-related panels, such as migraine, neuropathic pain, and abdominal pain. They also include endocrinology-related panels for hyper/hypoglycemia (MODY+), hyperparathyroidism, and pituitary hormone deficiency, and new neurology panels for neuromuscular disorders such as periodic paralysis, dystonia, and rhabdomyolysis.

Feb 09, 2017

EntroGen Sample Quality Assessment Products

EntroGen has launched two sample quality assessment products, the DNA Fragmentation Quantification assay and the Library Quantification kit for Illumina. Both products determine quantity and quality of DNA samples prior to running downstream qPCR. The DNA Fragmentation Quantification assay evaluates the amount of amplifiable DNA in a sample, and detects the presence of PCR inhibitors. The Library Quantification kit for Illumina utilizes primers designed to bind to P5 and P7 adaptor oligos for the detection of properly adaptor-indexed libraries for NGS sequencing on any Illumina instrument. 

Feb 08, 2017

Bioline JetSeq DNA Library Preparation Kits

Meridian Bioscience subsidiary, Bioline, has launched its JetSeq DNA Library Preparation kits. The kits, developed in collaboration with Oxford Gene Technology, use pre-optimized buffers to provide maximum reaction efficiency and highest conversion rates, the company said. They also  use a combination of end repair and A-tailing followed by direct ligation of customer supplied adapters to reduce clean-up steps, and improve yield and quality of sequence ready libraries. The kits come in PCR and PCR-free versions.

Feb 03, 2017

GenTegra Ahlstrom GenSaver Card

GenTegra and Ahlstrom have launched the Ahlstrom GenSaver collection card for dried blood spots. The card, which is available in several formats, protects DNA in dried blood spots for more than 20 years without freezing. It combines special paper and GenTegra-DNA Active Chemical Protection, a chemical matrix that helps preserve DNA in the dry state.  

Feb 03, 2017

Meridian Bioscience TruQuick

Meridian Bioscience has launched TruQuick, a comprehensive point-of-care product menu of rapid tests for the diagnosis of tropical, infectious, sexually transmitted, respiratory, gastrointestinal, cancer, and cardiac diseases. TruQuick is a qualitative lateral flow chromatographic immunoassay menu of over 60 products. Its rapid tests can aid in the diagnosis of infectious pathogens and other important acute diseases in 10 to 20 minutes, the company said. 

Feb 02, 2017

Biodesix's GeneStrat Includes ROS1 and RET Mutations

Biodesix has broadened its GeneStrat liquid biopsy test to include ROS1 and RET mutations in addition to EGFR sensitizing, EGFR resistance, KRAS, BRAF, and EML4-ALK alterations.

GeneStrat is a part of the Biodesix's larger "Lung Reflex" multi-omic liquid biopsy testing strategy, which also includes the VeriStrat proteomic testing. With results available within 72 hours, the company says that GeneStrat and VeriStrat together deliver comprehensive information for physicians to support critical treatment decisions at initial diagnosis, expediting appropriate treatment.

Feb 02, 2017

Sygnis TrueHelix

Sygnis has launched TrueHelix, a web-accessible bioinformatics platform for next-generation sequencing analysis services.

The first tool released on it will be TruePure, a sample purity validation service that checks for contamination from environmental or other sources.

Sygnis plans to add more tools over the rest of the year.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Mar
09
Sponsored by
Bio-Rad

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.